Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-141,495
Closed -$4.12M 692
2016
Q4
$4.12M Sell
141,495
-1,589
-1% -$46.2K 0.01% 371
2016
Q3
$3.93M Sell
143,084
-12,651
-8% -$347K 0.01% 368
2016
Q2
$3.4M Buy
155,735
+9,540
+7% +$208K 0.01% 373
2016
Q1
$3.27M Sell
146,195
-4,821
-3% -$108K 0.01% 367
2015
Q4
$4.18M Buy
151,016
+2,232
+2% +$61.7K 0.02% 340
2015
Q3
$3.84M Buy
148,784
+36,061
+32% +$930K 0.02% 330
2015
Q2
$2.79M Buy
112,723
+26,772
+31% +$664K 0.01% 362
2015
Q1
$2.17M Sell
85,951
-5,045
-6% -$127K 0.01% 373
2014
Q4
$2.13M Buy
90,996
+1,716
+2% +$40.3K 0.01% 375
2014
Q3
$2.03M Hold
89,280
0.01% 389
2014
Q2
$2.18M Sell
89,280
-2,487
-3% -$60.8K 0.01% 376
2014
Q1
$1.94M Buy
91,767
+20,942
+30% +$442K 0.01% 370
2013
Q4
$1.69M Buy
+70,825
New +$1.69M 0.01% 376

Other funds holding QGENF

Prudential plc's QGENF Position: Q1 2017 in Review

Prudential plc sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 141,495 shares — an estimated $4.12M sold.

Prudential plc first reported a position in QGENF in Q4 2013 and held it in 13 quarters. The position peaked at $4.18M in Q4 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Prudential plc reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Prudential plc sold 141,495 QIAGEN NV shares in Q1 2017, an estimated $4.12M.
  • Prudential plc first reported a position in QIAGEN NV in Q4 2013 and held it in 13 quarters.
  • Prudential plc's QIAGEN NV position peaked at $4.18M in Q4 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Prudential plc's 13F filing for Q1 2017, filed 15 May 2017.